Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19.
Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection: The Phase 2 DURVAST Study.
A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruption.
Dendritic Cells From the Cervical Mucosa Capture and Transfer HIV-1 via Siglec-1.
Enhancement of Antiviral CD8 + T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with Pembrolizumab.
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation.
Anti-Siglec-1 antibodies block Ebola viral uptake and decrease cytoplasmic viral entry.
Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study).
Cancer immunotherapy of patients with HIV infection.
Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMix.